NCT06216691

Brief Summary

A single arm, pilot study in which all eligible participants will be enrolled in an 8-week coach-guided smartphone delivered CBT program. The full duration of the program, with follow-up interview, will be 9 weeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

January 12, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 22, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2025

Completed
Last Updated

March 23, 2026

Status Verified

March 1, 2026

Enrollment Period

1.2 years

First QC Date

January 12, 2024

Last Update Submit

March 19, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Participants Engagement

    Percentage of participants who engage with at least 6/8 (75%) modules within the app

    from Baseline to 8 Weeks

  • Client Satisfaction Questionnaire-8 (CSQ-8)

    The CSQ-8 is an 8 item, self-reported questionnaire that measures satisfaction with clinical services received on a 1-4 scale. Scores are summed across items once. Items 2, 4, 5, and 8 are reverse scored. Total scores range from 8 to 32, with the higher number indicating greater satisfaction .

    change from baseline to Week 8

  • Patient Health Questionaire-9 (PHQ-9)

    The PHQ-9 is a widely used, reliable, and valid self-report measure of depression severity, It includes nine Likert scale items ranging from 0 (not at all) to 3 (every day), where higher scores indicate more severe depressive symptoms.

    Week 8

Secondary Outcomes (6)

  • Rate of participant dropout

    Week 8

  • user Mobile Health Rating Scale (uMARS)

    Week 8

  • Skindex-16

    Week 8

  • Appearance Anxiety Inventory (AAI)

    Week 8

  • Frequency of participants with adverse events

    Week 8

  • +1 more secondary outcomes

Study Arms (1)

Coach-guided smartphone delivered CBT program

OTHER

All eligible participants will be enrolled in an 8-week coach-guided smartphone delivered CBT program. The full duration of the program, with follow-up interview, will be 9 weeks.

Other: Coach-guided smartphone delivered CBT program.

Interventions

All eligible participants will be enrolled in an 8-week coach-guided smartphone delivered CBT program. The full duration of the program, with follow-up interview, will be 9 weeks.

Coach-guided smartphone delivered CBT program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 years of age and older
  • Dermatologist confirmed diagnosis of psoriasis
  • Current depression symptoms, defined as a PHQ-9 score of 5 or greater
  • Current psoriasis symptoms, defined as a scaled score of "mild" on any of the Skindex-16 subscales
  • Participants must be proficient in English and have access to an Android or iOS smartphone

You may not qualify if:

  • Previous participation in CBT for depression
  • Current participation in any type of psychotherapy
  • Those on psychotropic medications must be taking a stable dose for 2 months prior to enrollment and be willing to remain at a stable dose during the 8-week study
  • Current elevated suicide risk (see Section 5.3 for details)
  • Individuals who are incarcerated or compulsory detained
  • Any uncontrolled or poorly controlled chronic medical condition that may interfere with an individual's ability to participate in the clinical trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States

Location

MeSH Terms

Conditions

PsoriasisDepression

Condition Hierarchy (Ancestors)

Skin Diseases, PapulosquamousSkin DiseasesSkin and Connective Tissue DiseasesBehavioral SymptomsBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

January 12, 2024

First Posted

January 22, 2024

Study Start

January 1, 2024

Primary Completion

February 28, 2025

Study Completion

February 28, 2025

Last Updated

March 23, 2026

Record last verified: 2026-03

Locations